Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

作者：David G. Pfister, Sharon S. Spencer, David J. Adelstein, Douglas R. Adkins, Yoshimi Anzai, David M. Brizel, Justine Y. Bruce, Paul M. Busse, Jimmy J. Caudell, Anthony J. Cmelak, Alexander Dimitrios Colevas, David W. Eisele, Moon Jung Fenton, Robert L. Foote, Thomas James Galloway, Maura L. Gillison, Robert I. Haddad, Wesley L. Hicks, Ying J. Hitchcock, Antonio Jimeno, Debra S. Leizman, Ellie G. Maghami, Loren K. Mell, Bharat Bhushan Mittal, Harlan A. Pinto, John Andrew Ridge, James William Rocco, Cristina P. Rodriguez, Jatin P. Shah, Randal S. Weber, Gregory Steven Weinstein, Matthew E. Witek, Frank P. Worden, Sue S. Yom, Weining Ken Zhen, Jennifer L. Burns, Susan D. Darlow · 发表于：Journal of the National Comprehensive Cancer Network · 年份：2020 · DOI：10.6004/jnccn.2020.0031 · 被引用次数：1406 · 研究领域：Head and Neck Cancer Studies、Salivary Gland Tumors Diagnosis and Treatment、Cancer Diagnosis and Treatment

Treatment is complex for patients with head and neck (H&N) cancers with specific site of disease, stage, and pathologic findings guiding treatment decision-making. Treatment planning for H&N cancers involves a multidisciplinary team of experts. This article describes supportive care recommendations in the NCCN Guidelines for Head and Neck Cancers, as well as the rationale supporting a new section on imaging recommendations for patients with H&N cancers. This article also describes updates to treatment recommendations for patients with very advanced H&N cancers and salivary gland tumors, specifically systemic therapy recommendations.